1 documents found
Registration Number

0216U008321, 0115U002970 , R & D reports

Title

Experimental justification of CD150 isoforms application as potential diagnostic markers and targets for directed anti-tumor therapy

popup.stage_title

Head

Sidorenko Svitlana Pavlivna, Доктор біологічних наук

Registration Date

27-12-2016

Organization

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology

popup.description2

We created cell experimental model systems with the expression of nCD150 and mCD150 isoforms. As source of human cell lines used U87 and A172 (glioblastoma cell line), BLIN1 and REH (pre-B lymphoblastic leukemia), and HEK293-T (line of human embryonic kidney fibroblasts). we obtained HEK-293T-pBABEpuro, HEK-293T-pBABE-mCD150 and HEK-293T-pBABE-nCD150 transfectants. We obtained HEK-293T-pBABEpuro, HEK-293T-pBABE-mCD150 and HEK-293T-pBABE-nCD150 transfectants by using lipofectamine 2000. These transfectants will be used in further research for studies of the role mCD150 and nCD150 isoforms in cell signaling cascades.

Product Description

popup.authors

Гордієнко Інна Михайлівна
Ковалевська Лариса Миколаївна
Сидоренко Світлана Павлівна
Шлапацька Лариса Миколаївна

R & D report
Experimental justification of CD150 isoforms application as potential diagnostic markers and targets for directed anti-tumor therapy
Head: Sidorenko Svitlana Pavlivna. Experimental justification of CD150 isoforms application as potential diagnostic markers and targets for directed anti-tumor therapy. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0216U008321
1 documents found

Updated: 2024-12-22


Роздрукувати цю сторінку